Participant flow

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor · Source last updated 2026-07-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Stage IV and rapid complete response (RCR) of lung metastases continuously treated with DD4A after 6 weeks of DD4A.

   id

   FG000

   title

   Stage IV and Rapid Complete Response (RCR) of Lung Metastases

2. description

   Stage IV and slow incomplete response (SIR) of lung metastases treated with Regimen M after 6 weeks of DD4A.

   id

   FG001

   title

   Stage IV and Slow Incomplete Response (SIR) of Lung Metastases

3. description

   Stage III/IV with LOH 1p and 16q treated with Regimen M.

   id

   FG002

   title

   Stage III/IV With LOH 1p and 16q Treated With Regimen M

4. description

   Stage IV with non-lung disease treated with Regimen M.

   id

   FG003

   title

   Stage IV With Non-lung Disease Treated With Regimen M

5. description

   Stage IV with lung metastases treated with DD4A for less than 6 weeks and/or response inevaluable at week 6.

   id

   FG004

   title

   Stage IV With Lung Metastases

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         2

      5. group Id

         FG004

         num Subjects

         0

      type

      Death

   2. reasons

      1. group Id

         FG000

         num Subjects

         6

      2. group Id

         FG001

         num Subjects

         1

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         4

      5. group Id

         FG004

         num Subjects

         3

      type

      Lack of Efficacy

   3. reasons

      1. group Id

         FG000

         num Subjects

         6

      2. group Id

         FG001

         num Subjects

         2

      3. group Id

         FG002

         num Subjects

         1

      4. group Id

         FG003

         num Subjects

         2

      5. group Id

         FG004

         num Subjects

         3

      type

      Physician Decision

   4. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         1

      5. group Id

         FG004

         num Subjects

         0

      type

      Withdrawal by Subject

   5. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         1

      4. group Id

         FG003

         num Subjects

         1

      5. group Id

         FG004

         num Subjects

         7

      type

      Refusal of further protocol therapy

   6. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         2

      5. group Id

         FG004

         num Subjects

         0

      type

      On more than 1 tumor therapeutic study

   7. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         1

      5. group Id

         FG004

         num Subjects

         1

      type

      Delayed nephrectomy and anaplasia

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         120

      2. group Id

         FG001

         num Subjects

         135

      3. group Id

         FG002

         num Subjects

         52

      4. group Id

         FG003

         num Subjects

         50

      5. group Id

         FG004

         num Subjects

         23

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         107

      2. group Id

         FG001

         num Subjects

         132

      3. group Id

         FG002

         num Subjects

         50

      4. group Id

         FG003

         num Subjects

         37

      5. group Id

         FG004

         num Subjects

         9

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         13

      2. group Id

         FG001

         num Subjects

         3

      3. group Id

         FG002

         num Subjects

         2

      4. group Id

         FG003

         num Subjects

         13

      5. group Id

         FG004

         num Subjects

         14

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

The 15 discrepant patients were ineligible to the study. They were excluded in the Participant Flow table because none of them were treated by the protocol and their group designations were unknown.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice